Cybin (HELP) Free Cash Flow (2020 - 2025)
Cybin (HELP) reported Free Cash Flow of -$14.7 million for Q1 2025, up 4.41% on a YoY basis from -$14.1 million in Q1 2024, and up 24.22% quarter-over-quarter from -$19.4 million in Q4 2024.
Cybin (HELP) Free Cash Flow (2020 - 2025) Analysis & Trends
Cybin has reported Free Cash Flow for 6 years, with the latest figure at -$14.7 million in Q1 2025.
- For the quarter ending Q1 2025, Free Cash Flow rose 4.41% year-over-year to -$14.7 million; the trailing twelve-month figure through Jun 2025 stood at -$53.1 million (up 15.71% YoY), and the FY2025 full-year result was -$72.9 million, down 42.46% from the prior year.
- Free Cash Flow for Q1 2025 stood at -$14.7 million, up from -$19.4 million in the prior quarter.
- The five-year high for Free Cash Flow was $22.5 million in Q1 2022, with the low at -$19.9 million in Q2 2024.
- Historically, Free Cash Flow has averaged -$8.4 million across 5 years, with a median of -$10.5 million in 2021.
- Annual changes were most pronounced in 2021 — Free Cash Flow sank 521.04% — and 2023, when it gained 23.36%.
- Cybin's Free Cash Flow stood at -$10.1 million in 2021, then increased by 21.81% to -$7.9 million in 2022, then plunged by 141.07% to -$19.1 million in 2023, then decreased by 1.51% to -$19.4 million in 2024, then gained by 24.22% to -$14.7 million in 2025.
- The last three Free Cash Flow figures came in at -$14.7 million (Q1 2025), -$19.4 million (Q4 2024), and -$18.9 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -19.42 Mn |
| Dec 31, 2024 | -19.42 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Mar 31, 2024 | -15.39 Mn |
| Mar 31, 2024 | -15.39 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Sep 30, 2023 | -8.55 Mn |
| Sep 30, 2023 | -8.55 Mn |
| Jun 30, 2023 | -7.96 Mn |
| Jun 30, 2023 | -7.96 Mn |
| Feb 28, 2023 | 9.79 Mn |
| Feb 28, 2023 | 9.79 Mn |
| Dec 31, 2022 | -7.94 Mn |
| Dec 31, 2022 | -7.94 Mn |